Roseland, N.J., June 16, 2009 — Jennie Hodgen, Ph.D., and Bob Giblin, APR, have joined Intervet/Schering-Plough Animal Health in two newly created positions established to develop the animal-health company’s relationships within the food chain.
Hodgen joins the animal-health company as technical service specialist — meat science, and Giblin serves as manager of food industry communications. They will support the meat industry by deepening collaboration, partnerships and communications with retail grocery, restaurant and foodservice-management companies; meat distributors and suppliers; and food-industry organizations, policy makers and key influencers.
"As a partner to those directly supplying the food chain, it is vital that we understand and support all segments of the meat industry — from producers to consumers," says Eric Alsup, D.V.M., business unit director, fed cattle, Intervet/Schering-Plough Animal Health. "The globalization and integration of the food industry requires stronger relationships, collaboration and sharing of knowledge and ideas among all of us who — in one form or another — are responsible for the quality, safety, affordability and availability of today’s food supply. In creating these two new positions, we are improving our ability to build and support crucial relationships throughout the food chain, at levels where decisions are made that have profound impacts on our core customers —livestock producers."
Jennie Hodgen, technical service specialist – meat science
Prior to earning a doctorate in meat science and muscle biology from the University of Nebraska-Lincoln, Hodgen earned both a master’s degree in food science, with an emphasis in animal byproduct utilization, and a bachelor’s degree in animal and food science from Oklahoma State University in Stillwater, Okla.
Hodgen brings a host of research experience and food-science expertise to the position and most recently served as a food-safety consultant and teacher. As a consultant, she helped a pet-food company navigate regulations to gain export status for several products. She also helped create new-product ingredients and assisted in the development of Hazard Analysis and Critical Control Point (HACCP) plans and recall strategies for several small meat processors, food companies and a pet-food ingredient company.
While Hodgen has worked in numerous food-product categories, a significant amount of her experience has been working with animal proteins. From running all facets of meat processing to conducting consumer and trained sensory panels, she has employed her background to ensure safety, quality and efficiency in meat production.
Bob Giblin, manager of food industry communications
Giblin comes to Intervet/Schering-Plough Animal Health from the Wisconsin Department of Military Affairs, where he served most recently as interim deputy director of public affairs. Prior to that, he served as an account manager for issues management at the communications agency Charleston/Orwig and as senior public relations counsel and director of research, measurement and insight at the firm Morgan&Myers.
With a background in managing issues spanning the agriculture and food industries, Giblin has led and participated in efforts to influence market development, procurement strategies and corporate social responsibility/sustainability initiatives for leading agriculture and food companies and organizations. His experience with the food industry spans across the produce and protein markets. Giblin, who graduated from the University of Wisconsin-Madison and the Department of Defense Information School, will focus on outreach with industry partners up and down the food chain.
About Intervet/Schering-Plough Animal Health
Intervet/Schering-Plough Animal Health is a leader in research and dedicated to the development, production and marketing of innovative, high-quality animal-health products for all major farm and companion animal species. For more information about Intervet/Schering-Plough Animal Health visit: www.intervet.com and www.intervetusa.com.
Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription and consumer products as well as to animal health products. Schering-Plough’s vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, New Jersey, USA, and its website is www.schering-plough.com.
SCHERING-PLOUGH DISCLOSURE NOTICE: The information in this press release includes certain "forward-looking statements" within the meaning of the private Securities Litigation Reform Act of 1995, including statements related to expectations or forecasts of future events. Schering-Plough does not assume the obligation to update any forward-looking statement. Many factors could cause actual results to differ materially from Schering-Plough’s forward-looking statements, including market forces, economic factors, product availability, patent and other intellectual property protection, current and future branded, generic or over-the-counter competition, the regulatory process, and any developments following regulatory approval, among other uncertainties. For further details about these and other factors that may impact the forward-looking statements, see Schering-Plough’s Securities and Exchange Commission filings, including Part II, Item 1A "Risk Factors" in the Company’s first quarter 2009 10-Q, filed May 1, 2009.